Post-Hoc Live: How much is everyone in biopharma getting paid?

June 9, 2026 08:16 AM EDT PeoplePharma Live at 12:30 p.m.: How much is every­one in bio­phar­ma get­ting paid? Andrew Dunn Senior Biopharma Correspondent The one law of CEO pay pack­ages: They keep get­ting big­ger. Yes­ter­day, we pub­lished the first in­stall­ment of End­points News’ an­nu­al bio­phar­ma com­pen­sa­tion project. Fol­low­ing our analy­sis of the in­dus­try’s top-paid CEOs, we’ll break down what top sci­ence and med­ical lead­ers make, dig in­to me­di­an em­ploy­ee pay (and how that com­pares to CEOs) and un­veil the rich­est gold­en para­chutes, as well as an ex­am­i­na­tion of ex­ec­u­tive perks. You’ll be able to find all of that re­port­ing here. To­day at 12:30 p.m. ET, I’m join­ing our Ex­ec­u­tive Ed­i­tor Drew Arm­strong on Post-Hoc Live to dig in­to about the eye-pop­ping num­bers in some CEO pay pack­ages and the be­hind-the-scenes of how this re­port­ing comes to­geth­er. Putting all this da­ta to­geth­er in one place does more than just re­veal bio­phar­ma’s pay­roll. It al­so rais­es ques­tions about how these com­pa­nies think about lead­er­ship and pri­or­i­tize their bud­gets. Are there oth­er ways bio­phar­mas could spend some of the mil­lions go­ing to­ward ex­ec­u­tive pack­ages? Do CEOs ac­tu­al­ly get paid com­men­su­rate with their com­pa­ny’s suc­cess? How does pay af­fect in­cen­tives and glob­al com­pe­ti­tion? We’ll be live on YouTube to talk through those is­sues. You can al­so add us to your Google or Out­look cal­en­dars to get a re­minder. Shoot me a note if you have any ques­tions (or opin­ions) you want us to dis­cuss dur­ing the show. See you then! — An­drew Dunn, Se­nior Bio­phar­ma Cor­re­spon­dent AUTHOR Andrew Dunn Senior Biopharma Correspondent adunn@endpointsnews.com